(Press-News.org) CORVALLIS, Ore. – Fossil researchers have discovered a novel genus and species of tiny wasp with a mysterious, bulbous structure at the end of each antenna.
The female micro-wasp was described from 100-million-year-old Burmese amber in a study led by George Poinar Jr., who holds a courtesy appointment in the Oregon State University College of Science.
Poinar and Fernando Vega, an independent researcher based in Silver Spring, Maryland, have some ideas about the “clouds” on the antennae, but they don’t know for sure what they are.
“We could find no fossil or extant insect with such antennal structures,” said Poinar, an international expert in using plant and animal life forms preserved in amber to learn about the biology and ecology of the distant past. “We wondered how it could still fly with that weight.”
Micro-wasps are defined as those with an adult body length of less than 2 millimeters. There are thousands of species of these parasitic insects around today, spread among hundreds of genera, Poinar said. Some are useful for controlling scale insects, which can be crop pests, he added.
“This micro-wasp has a length of only 1.3 millimeters,” Poinar said. “That, as well as its 15-segment antennae, a deep cleft in the center of its head and characters of the wings distinguish it from all other micro-wasps. The unique, miniature cloudlike structures stuck to the antennae must have certainly been an annoyance to this tiny parasite.”
Since the researchers could not find such structures on any other insect, current or extinct, they can only make educated guesses as to what they could be.
“They could be tiny plant seeds, plant secretions or eggs from a host the wasp was parasitizing,” Poinar said. “There is a good possibility the micro-wasp was parasitizing scale insects since there is a male scale insect embedded in the same piece of amber. Whatever they are, discovering these is one of the things that makes our work so interesting, and challenging: finding dominant, unique features on extinct organisms.”
The scientists named the new specimen Caradiophyodus saradae. The genus takes its name from the Greek words for head (kara) and cleft (diaphyodus), and the species name is a nod to fellow scientist Sarada Krishnan.
Findings were published in the journal Life.
END
New type of tiny wasp comes with mysterious, cloud-like structures at ends of antennae
2023-10-05
ELSE PRESS RELEASES FROM THIS DATE:
Tirzepatide is as effective at treating early-onset type 2 diabetes as diabetes diagnosed later in life
2023-10-05
Tirzepatide is as effective at treating early-onset type 2 diabetes (T2D), a more aggressive form of the condition that normally responds less well to treatment, as it is at treating T2D diagnosed later in life, new research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found.
Tirzepatide belongs to a new class of drugs that mimic the effect of two hormones involved in blood sugar control and appetite suppression, ...
Commonly prescribed antibiotic, antipsychotic and prokinetic drugs are associated with a higher risk of sudden cardiac arrest (SCA) in people with type 2 diabetes, study finds
2023-10-05
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has identified a range of characteristics associated with a higher risk of sudden cardiac arrest in individuals with type 2 diabetes.
These include the some commonly prescribed antibiotic and antipsychotic drugs, prokinetics (drugs used to treat gastrointestinal symptoms such as nausea and vomiting) and low fasting blood sugar.
Sudden cardiac arrest (SCA) is a leading cause of death. ...
Study reveals distinct illness trajectory in the years leading up to type 2 diabetes diagnosis
2023-10-05
New research presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), reveals a marked increase in several common conditions in the years leading up to, and immediately prior to, type 2 diabetes diagnosis, suggesting considerably earlier diagnosis might be possible in some patients.
“These novel insights into the onset and natural progression of type 2 diabetes, suggest an early phase of inflammation-related disease activity long before any clinical diagnosis of type 2 diabetes is made”, says senior author Dr Adrian Heald from Manchester ...
Is lasting remission of type 2 diabetes feasible in the real-world setting?
2023-10-05
At this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) experts will discuss if lasting remission from diabetes is feasible in the real-world setting.
Professor Roy Taylor of Newcastle University, Newcastle, UK, will be speaking in support of the motion
Professor Taylor will argue that through a series of studies in which people with type 2 diabetes were put on low calorie diets, he has shown that lasting remission of type 2 diabetes is indeed feasible in the real world.
He will begin ...
Second international consensus report - clinical translation of precision diabetes medicine
2023-10-05
Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimise outcomes when making medical decisions and health recommendations. Diabetes affects hundreds of millions of people worldwide, many of whom will develop life-threatening complications and die prematurely.
“Diabetes recommendations often focus on what works well for the average person. However, because diabetes is an incredibly heterogeneous disease, few people are Mr or Mrs “average” and one-size-fits-all ...
Wastewater surveillance research provides a 12-day lead time for RSV season: new study
2023-10-04
In a first-of-its-kind study, researchers using wastewater surveillance over conventional indicators have predicted the start of the annual respiratory syncytial virus (RSV) season 12 days early, providing more lead time for hospital preparedness and the timely initiation of RSV prevention therapy provided by the province for at risk-infants and young children.
Published in Frontiers in Public Health, the study is the first to describe the relationship between wastewater measurements and clinical data for RSV and to use near real-time wastewater measurements to accurately identify the start of the RSV season.
Working in close collaboration with CHEO Research Institute (RI) ...
Unmet health needs for HIV, hypertension and diabetes in rural South Africa
2023-10-04
The burden of non-communicable diseases like hypertension and diabetes is increasing globally, especially in low-income and middle-income countries where they occur alongside epidemics of communicable diseases like HIV. A large public health survey in South Africa led by Emily Wong, M.D., has assessed the multimorbidity health needs of individuals and communities in rural KwaZulu-Natal and established a framework to quantify met and unmet health needs for individuals living with infectious and non-communicable diseases. The study is published in The Lancet Global Health.
“Applying ...
Blood-based biomarker may redefine the future treatment for advanced melanoma
2023-10-04
Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma. A new study that assessed ctDNA in the blood of patients with BRAF wild-type (BRAF WT) stage III and IV melanoma concludes that measuring ctDNA may lead to alternative treatment options and better outcomes for these patients, report investigators in The Journal of Molecular Diagnostics, published by Elsevier.
For patients with BRAF WT stage III and IV melanoma, there is an urgent clinical need to identify prognostic biomarkers and biomarkers to predict treatment ...
Advances from MSK researchers reported at 2023 ASTRO Meeting
2023-10-04
Researchers from Memorial Sloan Kettering Cancer Center (MSK) were recognized for their achievements at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology. Teams reported new findings about radiation-induced secondary cancers, a new guidance system for radiation therapy, and the consequences of insurance denials, among other topics.
At the meeting, held from October 1 to October 4, 2023, in San Diego, Simon Powell, MD, PhD, FRCP, Chair of MSK’s Department of Radiation Oncology and Enid A. Haupt Chair in Radiation Oncology, was honored with ASTRO’s Gold Medal Award. This award is ASTRO’s highest honor, bestowed upon ...
Ketamine-related drug gives better treatment for difficult to treat clinical depression
2023-10-04
Type of work: peer-reviewed/clinical trial/people
A major clinical trial shows that the drug, esketamine, one of the two main forms of ketamine, outperforms one of the standard treatments for treatment-resistant major depression. This industry-funded work is presented for the first time at the 36th ECNP Congress in Barcelona, with publication in the peer-reviewed journal the New England Journal of Medicine (see Notes for details).
Clinical depression (also known as MDD, major depressive disorder) affects a significant number of people at any one time, giving ...